C07C 255/21
The carbon skeleton being further substituted by doubly-bound oxygen atoms
Official title: the carbon skeleton being further substituted by doubly-bound oxygen atoms
C07C255/21 (The carbon skeleton being further substituted by doubly-bound oxygen atoms) appears on 47 US grants and 25 published applications in this corpus.
Search patents in C07C- Granted patents
- 47
- Published applications
- 25
- Assignees
- 15
- Inventors
- 74
- Latest grant
- 9 Mar 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 7 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 12 | 5 |
| 2003 | 3 | 13 |
| 2004 | 14 | 1 |
| 2005 | 1 | 2 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Compositions and methods of treatment using a BCAT1 inhibitor9 Mar 2021US 10,941,109 B2Ergon Pharmaceuticals LLC
- Processes for the preparation of diastereomerically and enantiomerically enriched oxazolines24 Mar 2020US 10,597,353 B2Quimica Sintetica, S.A.
- Process for the preparation of tert-butyl 6-cyano-5-hydroxy-3-oxohexanoate7 Jul 2009US 7,557,238 B2Biocon Limited
- Process for the synthesis of 1,3-diols19 Jun 2007US 7,232,915 B2Warner-Lambert Company
- Process for the synthesis of 1,3-diols8 Nov 2005US 6,962,994 B2Warner-Lambert Company
- Adamantane amides and thioamides for the treatment of ebolavirus infection18 Jul 2024US 2024/0238265 A1Arisan Therapeutics Inc.
- Processes for the preparation of diastereomerically and enantiomerically enriched oxazolines15 Nov 2018US 2018/0327349 A1Quimica Sintetica, S.A.
- Compositions and methods of treatment using a bcat1 inhibitor22 Dec 2016US 2016/0368862 A1Ergon Pharmaceuticals LLC
- Dicyano Alkanoic Acid Amides for Combating Animal Pests18 Sep 2008US 2008/0227635 A1BASF SE
- Process for the synthesis of 1,3-diols8 Sep 2005US 2005/0197500 A1Warner-Lambert Company
Most cited
By later US patents
- Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate75US 5,155,251 AWarner-Lambert Company · 1992
- Process for the synthesis of 1,3-diols38US 6,433,213 B1Warner-Lambert Company · 2002
- Process for the synthesis of 1,3-diols36US 6,596,879 B2Warner-Lambert Company · 2003
- Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors28US 5,789,434 ABayer Aktiengesellschaft · 1998
- Inhibitors of neutral endopeptidase/CALLA as chemotherapeutic agents18US 5,200,426 ABoard of Regents, The University of Texas · 1993